Abstract
Survivin is a cancer gene implicated in inhibition of apoptosis and regulation of mitosis, but its function in normal cells has remained elusive. Here, we show that transgenic mice expressing survivin in pancreatic islet β-cells show no changes in cell proliferation, as determined by islet size or islet number. Transplantation of survivin transgenic islets in diabetic recipient mice affords long-term engraftment and stable correction of hyperglycaemia. This involves intrinsic inhibition of β-cell apoptosis, in vivo, and global transcriptional changes in pancreatic islets with upregulation of stress response genes, antagonists of cytokine signalling and promoters of angiogenesis. These broad cytoprotective functions of survivin in vivo might be beneficial for gene therapy of diabetes.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 438-443 |
| Number of pages | 6 |
| Journal | EMBO Reports |
| Volume | 7 |
| Issue number | 4 |
| DOIs | |
| State | Published - Apr 2006 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
All Science Journal Classification (ASJC) codes
- Biochemistry
- Molecular Biology
- Genetics
Fingerprint
Dive into the research topics of 'Inhibition of apoptosis by survivin improves transplantation of pancreatic islets for treatment of diabetes in mice'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver